Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 14951-15000 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT04181476
Efficacy Evaluation of Products Against Long Wavelength Ultraviolet A1 and Visible Light Induced Biological Effects
PHASE2
Active, not recruiting
12 participants
Started: Nov 5, 2019 · Completed: Jun 30, 2022
1 condition
2 sponsors
1 location
NCT03831464
Metformin as RenoProtector of Progressive Kidney Disease
PHASE3
Active, not recruiting
290 participants
Started: Nov 5, 2019 · Completed: Dec 31, 2024
1 condition
2 sponsors
19 locations
NCT04147494
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues
EARLY_PHASE1
Active, not recruiting
29 participants
Started: Nov 5, 2019 · Completed: Oct 17, 2031
11 conditions
2 sponsors
1 location
NCT04034810
Safety and Efficacy of Silk Vista and Silk Vista Baby Flow Diverter for Intracranial Aneurysm Treatment
N/A
Active, not recruiting
234 participants
Started: Nov 4, 2019 · Completed: Nov 30, 2027
2 conditions
1 sponsor
29 locations
NCT04111458
A Study to Test Different Doses of BI 1701963 Alone and Combined With Trametinib in Patients With Different Types of Advanced Cancer (Solid Tumours With KRAS Mutation)
PHASE1
Active, not recruiting
71 participants
Started: Nov 4, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
8 locations
NCT03975829
Pediatric Long-Term Follow-up and Rollover Study
PHASE4
Active, not recruiting
163 participants
Started: Nov 4, 2019 · Completed: Jul 23, 2026
23 conditions
1 sponsor
55 locations
NCT04150783
Computational Modeling of Cleft Lip Nasal Deformity and Assessment of Nasal Function and Treatment Outcomes
N/A
Active, not recruiting
12 participants
Started: Nov 1, 2019 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT04151134
Evaluation of Tongue Base MucOsectomy & Step sErial Sectioning
N/A
Active, not recruiting
100 participants
Started: Nov 1, 2019 · Completed: Dec 1, 2028
1 condition
3 sponsors
1 location
NCT07030413
Weaning From High Flow Nasal Oxygen in Acute Respiratory Failure : a Target Trial Emulation
N/A
Active, not recruiting
2,000 participants
Started: Nov 1, 2019 · Completed: Dec 31, 2025
3 conditions
3 sponsors
3 locations
NCT06488937
Biomarkers Associated With Temporomandibular Disorders in Patients With Rheumatoid Arthritis
N/A
Active, not recruiting
92 participants
Started: Nov 1, 2019 · Completed: Feb 28, 2025
2 conditions
2 sponsors
1 location
NCT04098211
Longitudinal Assessment of Atypical Tripeptidyl Peptidase 1 Enzyme Deficiency Patients
N/A
Active, not recruiting
5 participants
Started: Nov 1, 2019 · Completed: Dec 31, 2024
3 conditions
1 sponsor
1 location
NCT04058561
Hospital-Based Cluster Trial: Magnetically Controlled Growing Rods Using Distraction Intervals
NA
Active, not recruiting
210 participants
Started: Nov 1, 2019 · Completed: Dec 31, 2027
1 condition
2 sponsors
20 locations
NCT06090643
Implementation Research to Increase Colorectal Cancer Screening Rates Among Low Income and Ethnic Minority Groups
NA
Active, not recruiting
9,745 participants
Started: Nov 1, 2019 · Completed: Nov 1, 2026
1 condition
2 sponsors
1 location
NCT04707326
Defining the Potency of DTG/3TC for Suppressed HIV Patients in Real-life: the DUALING Study
N/A
Active, not recruiting
2,040 participants
Started: Nov 1, 2019 · Completed: Nov 1, 2026
1 condition
9 sponsors
9 locations
NCT04173104
PET and MRI Imaging of Brain Tumors Using [18F]PARPi
EARLY_PHASE1
Active, not recruiting
5 participants
Started: Nov 1, 2019 · Completed: Nov 30, 2025
2 conditions
1 sponsor
1 location
NCT03979014
Nonavalent Prophylactic HPV Vaccine (GARDASIL9) After Local Conservative The NOVEL Trial
PHASE3
Active, not recruiting
1,000 participants
Started: Nov 1, 2019 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT03887988
Orbital Fractures Registry
N/A
Active, not recruiting
300 participants
Started: Nov 1, 2019 · Completed: Jun 30, 2025
2 conditions
1 sponsor
14 locations
NCT04155346
Prehab for Surgery
NA
Active, not recruiting
150 participants
Started: Nov 1, 2019 · Completed: Dec 31, 2024
2 conditions
3 sponsors
1 location
NCT02581085
Tocotrienol Against the Progression of End Stage Liver Disease
PHASE2
Active, not recruiting
70 participants
Started: Nov 1, 2019 · Completed: Dec 31, 2028
3 conditions
3 sponsors
1 location
NCT03935958
Curcumin in Kidney Transplant Recipients
NA
Active, not recruiting
14 participants
Started: Nov 1, 2019 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT04082234
Reducing Disparities in Behavioral Health Treatment for Children in Primary Care
NA
Active, not recruiting
300 participants
Started: Nov 1, 2019 · Completed: Mar 31, 2026
1 condition
2 sponsors
1 location
NCT03940209
Addressing Basic Needs to Improve Diabetes Outcomes in Medicaid Beneficiaries
PHASE2
Active, not recruiting
473 participants
Started: Nov 1, 2019 · Completed: Jun 30, 2024
1 condition
3 sponsors
1 location
NCT05101824
Bony M - Stereotactic Ablative Radiotherapy (SABR) of Bony Metastases in Patients With Oligometastatic Disease
NA
Active, not recruiting
67 participants
Started: Nov 1, 2019 · Completed: Nov 1, 2027
3 conditions
1 sponsor
6 locations
NCT05911451
Optimizing Access Surgery In Senior Hemodialysis Patients
NA
Active, not recruiting
166 participants
Started: Nov 1, 2019 · Completed: Mar 31, 2026
6 conditions
2 sponsors
20 locations
NCT04088773
Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's Disease
N/A
Active, not recruiting
232 participants
Started: Nov 1, 2019 · Completed: Jun 30, 2026
1 condition
2 sponsors
4 locations
NCT04100733
Surveillance of High-grade Non-muscle Invasive Bladder Tumours Using the Xpert Bladder Cancer Monitor
NA
Active, not recruiting
392 participants
Started: Nov 1, 2019 · Completed: Apr 30, 2027
2 conditions
2 sponsors
3 locations
NCT04166565
Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease
PHASE2
Active, not recruiting
41 participants
Started: Oct 31, 2019 · Completed: Mar 31, 2027
2 conditions
2 sponsors
8 locations
NCT04110327
An All-Comers Observational Study of the MicroStent™ Peripheral Vascular Stent System in Subjects With Peripheral Arterial Disease
N/A
Active, not recruiting
300 participants
Started: Oct 31, 2019 · Completed: Dec 31, 2028
2 conditions
1 sponsor
10 locations
NCT04175301
Effect H2 Water on QoL of Patients Receiving Radiotherapy for High Grade Gliomas.
PHASE2
Active, not recruiting
15 participants
Started: Oct 31, 2019 · Completed: Sep 30, 2027
1 condition
1 sponsor
1 location
NCT04036682
A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer
PHASE1/PHASE2
Active, not recruiting
284 participants
Started: Oct 31, 2019 · Completed: Mar 31, 2026
2 conditions
1 sponsor
64 locations
NCT04328233
Impact of Time-Restricted Eating on Metabolic Homeostasis, Inflammation and Oxidative Stress in Metabolic Syndrome
NA
Active, not recruiting
30 participants
Started: Oct 31, 2019 · Completed: Dec 31, 2024
5 conditions
4 sponsors
1 location
NCT04130542
Phase 1 Trial of LVGN6051 as Single Agent and in Combination With Keytruda (Pembrolizumab) in Advanced or Metastatic Malignancy
PHASE1
Active, not recruiting
276 participants
Started: Oct 31, 2019 · Completed: Dec 31, 2025
1 condition
2 sponsors
7 locations
NCT03891784
Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors
PHASE2
Active, not recruiting
20 participants
Started: Oct 31, 2019 · Completed: Sep 30, 2027
9 conditions
2 sponsors
2 locations
NCT04130737
TORUS 2 IDE Clinical Study
NA
Active, not recruiting
188 participants
Started: Oct 31, 2019 · Completed: Dec 24, 2024
1 condition
3 sponsors
32 locations
NCT03787680
Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)
PHASE2
Active, not recruiting
49 participants
Started: Oct 31, 2019 · Completed: Aug 31, 2028
1 condition
1 sponsor
3 locations
NCT04099394
Pain & Aging: Combined Interventions for Fitness in the Community Study
NA
Active, not recruiting
280 participants
Started: Oct 30, 2019 · Completed: Jan 31, 2025
1 condition
2 sponsors
1 location
NCT04589598
Femoral Neck System and Multiple Cannulated Screws in Femoral Neck Fracture
NA
Active, not recruiting
620 participants
Started: Oct 30, 2019 · Completed: Oct 30, 2025
1 condition
2 sponsors
1 location
NCT04148430
A Study of Anakinra to Prevent or Treat Severe Side Effects for Patients Receiving CAR-T Cell Therapy
PHASE2
Active, not recruiting
62 participants
Started: Oct 30, 2019 · Completed: Oct 31, 2025
3 conditions
1 sponsor
2 locations
NCT04058756
Rollover Study for Continued Safety and Tolerability in Subjects Treated With Spartalizumab Alone or in Combination With Other Study Treatments
PHASE1
Active, not recruiting
120 participants
Started: Oct 30, 2019 · Completed: Apr 30, 2030
1 condition
1 sponsor
48 locations
NCT04108624
Study to Assess for Measurable Residual Disease (MRD) in Multiple Myeloma Patients
NA
Active, not recruiting
56 participants
Started: Oct 30, 2019 · Completed: Feb 1, 2026
1 condition
1 sponsor
1 location
NCT03796884
Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer
PHASE2
Active, not recruiting
230 participants
Started: Oct 30, 2019 · Completed: Jun 30, 2026
11 conditions
2 sponsors
3 locations
NCT04207177
Immunosuppressive Drugs and Gut Microbiome: Pharmacokinetic- and Microbiome Diversity Effects
PHASE4
Active, not recruiting
100 participants
Started: Oct 30, 2019 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT04094688
Vitamin D3 with Chemotherapy and Bevacizumab in Treating Patients with Advanced or Metastatic Colorectal Cancer
PHASE3
Active, not recruiting
455 participants
Started: Oct 29, 2019 · Completed: Jul 1, 2026
1 condition
2 sponsors
1031 locations
NCT04157348
Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab.
PHASE3
Active, not recruiting
140 participants
Started: Oct 29, 2019 · Completed: Mar 31, 2026
1 condition
1 sponsor
50 locations
NCT03804229
Efficacy and Safety of Butylphthalide Soft Capsule for the Treatment of Vascular Dementia
PHASE3
Active, not recruiting
707 participants
Started: Oct 29, 2019 · Completed: Feb 7, 2025
1 condition
2 sponsors
1 location
NCT03865082
Study of Tilsotolimod in Combination With Nivolumab and Ipilimumab for the Treatment of Solid Tumors (ILLUMINATE-206)
PHASE2
Active, not recruiting
30 participants
Started: Oct 29, 2019 · Completed: Apr 30, 2022
1 condition
2 sponsors
3 locations
NCT04099251
Effectiveness Study of Nivolumab Compared to Placebo in Prevention of Recurrent Melanoma After Complete Resection of Stage IIB/C Melanoma
PHASE3
Active, not recruiting
790 participants
Started: Oct 28, 2019 · Completed: Jun 29, 2027
1 condition
1 sponsor
130 locations
NCT04304209
Pd1 Antibody Sintilimab ± Chemoradiotherapy for Locally Advanced Rectal Cancer
PHASE2
Active, not recruiting
195 participants
Started: Oct 28, 2019 · Completed: Oct 18, 2026
2 conditions
1 sponsor
1 location
NCT03781986
APG-115 in Salivary Gland Cancer Trial
PHASE1/PHASE2
Active, not recruiting
41 participants
Started: Oct 28, 2019 · Completed: Jun 30, 2026
2 conditions
2 sponsors
3 locations
NCT04269304
Deciphering AMD by Deep Phenotyping and Machine Learning- Prospective Study - PINNACLE
N/A
Active, not recruiting
429 participants
Started: Oct 28, 2019 · Completed: Jun 30, 2025
1 condition
7 sponsors
12 locations
Previous
1
More pages
297
298
299
300
301
302
303
More pages
431
Next